obacunone has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XN; Liu, L; Qiu, S; Sun, H; Wang, XJ; Xie, J; Yan, GL; Zhang, AH; Zhang, TL | 1 |
| Jayaprakasha, GK; Murthy, KN; Patil, BS | 1 |
2 other study(ies) available for obacunone and Prostatic Neoplasms
| Article | Year |
|---|---|
Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoxepins; Cell Proliferation; Humans; Limonins; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Prostatic Neoplasms; Tumor Cells, Cultured | 2019 |
Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death.
Topics: Apoptosis; Benzoxepins; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Citrus paradisi; Cytochromes c; DNA Fragmentation; Dose-Response Relationship, Drug; Down-Regulation; Glucosides; Humans; Inflammation; Limonins; Male; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Signal Transduction; Triterpenes | 2015 |